Abstract
Quantitative structure – activity relationships (QSAR) is a well established ligand-based approach to drug design. It correlates changes in the chemical structure of a series of compounds with changes in their biological activities. Peptides of equal length which bind to a certain protein are an excellent target for QSAR. In the present review, we summarize our experience in QSAR studies of peptides acting as T-cell epitopes. T-cell epitopes are protein fragments presented on the cell surface which afford the immune system the opportunity to detect and respond to both intracellular and extracellular pathogens. Epitope-based vaccines are a new generation of vaccines with lower side effects. The process of antigen presentation, which includes proteasome cleavage, TAP and MHC binding, has been modeled and analyzed by QSAR. Derived QSAR models are highly predictive, allowing us to design and test in vitro MHC superbinders. All models have been implemented in servers for in silico prediction of MHC binders and T-cell epitopes. In practice, better initial in silico prediction leads to improved subsequent experimental research on epitope-based vaccines.
Keywords: Proteasome, TAP, MHC class I, MHC class II, additive method
Current Proteomics
Title: QSAR and the Prediction of T-Cell Epitopes
Volume: 5 Issue: 2
Author(s): Irini A. Doytchinova and Darren R. Flower
Affiliation:
Keywords: Proteasome, TAP, MHC class I, MHC class II, additive method
Abstract: Quantitative structure – activity relationships (QSAR) is a well established ligand-based approach to drug design. It correlates changes in the chemical structure of a series of compounds with changes in their biological activities. Peptides of equal length which bind to a certain protein are an excellent target for QSAR. In the present review, we summarize our experience in QSAR studies of peptides acting as T-cell epitopes. T-cell epitopes are protein fragments presented on the cell surface which afford the immune system the opportunity to detect and respond to both intracellular and extracellular pathogens. Epitope-based vaccines are a new generation of vaccines with lower side effects. The process of antigen presentation, which includes proteasome cleavage, TAP and MHC binding, has been modeled and analyzed by QSAR. Derived QSAR models are highly predictive, allowing us to design and test in vitro MHC superbinders. All models have been implemented in servers for in silico prediction of MHC binders and T-cell epitopes. In practice, better initial in silico prediction leads to improved subsequent experimental research on epitope-based vaccines.
Export Options
About this article
Cite this article as:
Doytchinova A. Irini and Flower R. Darren, QSAR and the Prediction of T-Cell Epitopes, Current Proteomics 2008; 5 (2) . https://dx.doi.org/10.2174/157016408784911945
DOI https://dx.doi.org/10.2174/157016408784911945 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Design of Telomerase Inhibitors for the Treatment of Cancer
Current Pharmaceutical Design Non Smoking for Successful Aging: Therapeutic Perspectives
Current Pharmaceutical Design Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology Cancer and Treatment Modalities
Current Cancer Therapy Reviews Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery Protective Mechanisms of Helminths Against Reactive Oxygen Species are Highly Promising Drug Targets
Current Medicinal Chemistry Genitourinary Tract Tumors in Children: An Update
Current Pediatric Reviews The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Current Pharmaceutical Design In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Current Pharmaceutical Design Androgen Pathway Related Gene Variants and Prostate Cancer Association in Auckland Men
Current Pharmacogenomics and Personalized Medicine A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis
Current Cancer Therapy Reviews Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Current Drug Therapy Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
Current Medicinal Chemistry Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Current Cancer Therapy Reviews